Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 37 | $8,107,801 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
11 Mar 2024 16:09 | AGIO | AGIOS PHARMACEUTICALS Inc | FOSTER-CHEEK KAYE I | Director | 07 Mar 2024 | Sale | 1,285 | 31.62 | 40,632 | D |
07 Mar 2024 18:47 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 05 Mar 2024 | Sale | 1,913 | 31.75 | 60,738 | D |
07 Mar 2024 18:49 | AGIO | AGIOS PHARMACEUTICALS Inc | FOSTER-CHEEK KAYE I | Director | 05 Mar 2024 | Sale | 300 | 32.21 | 9,663 | D |
07 Mar 2024 18:49 | AGIO | AGIOS PHARMACEUTICALS Inc | FOSTER-CHEEK KAYE I | Director | 06 Mar 2024 | Sale | 4,415 | 31.99 | 141,236 | D |
05 Mar 2024 16:20 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 05 Mar 2024 | Sale | 1,349 | 32.57 | 43,937 | D |
05 Mar 2024 16:20 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 05 Mar 2024 | Sale | 1,293 | 32.57 | 42,113 | D |
05 Mar 2024 16:15 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 05 Mar 2024 | Sale | 919 | 32.57 | 29,932 | D |
05 Mar 2024 16:15 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 05 Mar 2024 | Sale | 295 | 32.57 | 9,608 | D |
05 Mar 2024 16:18 | AGIO | AGIOS PHARMACEUTICALS Inc | JONES CECILIA | Chief Financial Officer | 05 Mar 2024 | Sale | 672 | 32.57 | 21,887 | D |
05 Mar 2024 16:10 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 05 Mar 2024 | Sale | 4,156 | 32.57 | 135,361 | D |
05 Mar 2024 16:08 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 05 Mar 2024 | Sale | 1,349 | 32.57 | 43,937 | D |
05 Mar 2024 16:08 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 05 Mar 2024 | Sale | 1,293 | 32.57 | 42,113 | D |
29 Feb 2024 16:05 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 27 Feb 2024 | Sale | 57,471 | 34.89 | 2,005,163 | D |
29 Feb 2024 16:05 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 27 Feb 2024 | Sale | 11,858 | 33.6 | 398,429 | D |
27 Feb 2024 16:04 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 26 Feb 2024 | Sale | 20,411 | 33.19 | 677,441 | D |
27 Feb 2024 16:04 | AGIO | AGIOS PHARMACEUTICALS Inc | SCHENKEIN DAVID P | Director | 23 Feb 2024 | Sale | 47,731 | 33.05 | 1,577,510 | D |
22 Feb 2024 17:43 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 20 Feb 2024 | Sale | 504 | 26.63 | 13,422 | D |
14 Feb 2024 17:50 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 14 Feb 2024 | Sale | 273 | 25.14 | 6,863 | D |
14 Feb 2024 17:51 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 14 Feb 2024 | Sale | 545 | 25.14 | 13,701 | D |
14 Feb 2024 17:53 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 14 Feb 2024 | Sale | 642 | 25.14 | 16,140 | D |
24 Jan 2024 16:24 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 24 Jan 2024 | Sale | 1,708 | 21.64 | 36,961 | D |
24 Jan 2024 16:25 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 24 Jan 2024 | Sale | 1,708 | 21.64 | 36,961 | D |
24 Jan 2024 16:20 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 24 Jan 2024 | Sale | 7,635 | 21.64 | 165,221 | D |
24 Jan 2024 16:22 | AGIO | AGIOS PHARMACEUTICALS Inc | FOUSE JACQUALYN A | Director | 24 Jan 2024 | Sale | 10,722 | 21.64 | 232,024 | D |
24 Jan 2024 16:23 | AGIO | AGIOS PHARMACEUTICALS Inc | JONES CECILIA | Chief Financial Officer | 24 Jan 2024 | Sale | 1,886 | 21.64 | 40,813 | D |
24 Jan 2024 16:19 | AGIO | AGIOS PHARMACEUTICALS Inc | MILANOVA TSVETA | Chief Commercial Officer | 24 Jan 2024 | Sale | 1,618 | 21.64 | 35,014 | D |
09 Jan 2024 16:25 | AGIO | AGIOS PHARMACEUTICALS Inc | BURNS JAMES WILLIAM | Chief Legal Officer | 09 Jan 2024 | Sale | 1,163 | 22.99 | 26,737 | D |
09 Jan 2024 16:26 | AGIO | AGIOS PHARMACEUTICALS Inc | FOUSE JACQUALYN A | Director | 09 Jan 2024 | Sale | 8,391 | 22.99 | 192,909 | D |
09 Jan 2024 16:28 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 09 Jan 2024 | Sale | 12,066 | 22.99 | 277,397 | D |
09 Jan 2024 16:22 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 09 Jan 2024 | Sale | 1,789 | 22.99 | 41,129 | D |
05 Jan 2024 16:10 | AGIO | AGIOS PHARMACEUTICALS Inc | MILANOVA TSVETA | Chief Commercial Officer | 05 Jan 2024 | Sale | 2,902 | 22.32 | 64,773 | D |
12 Aug 2024 17:15 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 08 Aug 2024 | Sale | 11,091 | 42.75 | 474,140 | D |
03 Jul 2024 16:30 | AGIO | AGIOS PHARMACEUTICALS Inc | GHEUENS SARAH | Chief Medical Officer | 01 Jul 2024 | Sale | 3,705 | 43.85 | 162,464 | D |
07 Jun 2024 16:25 | AGIO | AGIOS PHARMACEUTICALS Inc | GOFF BRIAN | Chief Executive Officer | 05 Jun 2024 | Sale | 12,115 | 48.84 | 591,697 | D |
05 Jun 2024 16:14 | AGIO | AGIOS PHARMACEUTICALS Inc | WASHBURN THEODORE JAMES JR. | Principal Accounting Officer | 03 Jun 2024 | Sale | 1,362 | 44.39 | 60,459 | D |
10 Apr 2024 16:03 | AGIO | AGIOS PHARMACEUTICALS Inc | FOUSE JACQUALYN A | Director | 10 Apr 2024 | Sale | 7,791 | 27.55 | 214,642 | D |
30 Sep 2024 16:15 | AGIO | AGIOS PHARMACEUTICALS Inc | JONES CECILIA | Chief Financial Officer | 26 Sep 2024 | Sale | 2,542 | 49.03 | 124,634 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)